1. Home
  2. SAGE
  3. SAGE News

Latest Sage Therapeutics Inc. (SAGE) News on July 26, 2024

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
SAGE

Zacks

10 hours ago

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

SAGE

MT Newswires

a day ago

Baird Adjusts Price Target on Sage Therapeutics to $13 From $15, Maintains Neutral Rating

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
SAGE

Zacks

a day ago

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?

SAGE

MT Newswires

2 days ago

Morgan Stanley Halves Price Target on Sage Therapeutics to $11 From $22, Keeps Equalweight Rating

SAGE

MT Newswires

2 days ago

JPMorgan Downgrades Sage Therapeutics to Neutral From Overweight, Adjusts Price Target to $12 From $18

Sage and Biogen’s SAGE-324 shows no benefit in essential tremor trial
SAGE

Clinical Trials Arena

2 days ago

Sage and Biogen’s SAGE-324 shows no benefit in essential tremor trial

Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails
SAGE

Investor's Business Daily

2 days ago

Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails

SAGE

MT Newswires

2 days ago

Sage Therapeutics, Biogen Stop Development of Investigational Drug for Essential Tremor

Sage Therapeutics Stock Slides as Pipeline Thins
SAGE

Barrons.com

2 days ago

Sage Therapeutics Stock Slides as Pipeline Thins

SAGE

MT Newswires

2 days ago

Wedbush Adjusts Sage Therapeutics' PT to $9 From $15, Maintains Neutral Rating

Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
SAGE

Zacks

2 days ago

Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Biogen, Sage tremor drug fails key trial
SAGE

BioPharma Dive

2 days ago

Biogen, Sage tremor drug fails key trial

Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor
SAGE

Business Wire

3 days ago

Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor

Sage Therapeutics/Biogen’s episodic therapy zuranolone could change MDD treatment
SAGE

Clinical Trials Arena

5 days ago

Sage Therapeutics/Biogen’s episodic therapy zuranolone could change MDD treatment

SAGE Rides on Zurzuvae Sales, Pipeline Setbacks a Concern
SAGE

Zacks

7 days ago

SAGE Rides on Zurzuvae Sales, Pipeline Setbacks a Concern

SAGE

MT Newswires

7 days ago

Mizuho Securities Lowers Adjusts Price Target on Sage Therapeutics to $16 From $18, Maintains Neutral Rating

Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024
SAGE

Business Wire

10 days ago

Sage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024

SAGE

MT Newswires

14 days ago

JPMorgan Lowers Price Target on Sage Therapeutics to $18 From $23, Maintains Overweight Rating

SAGE

MT Newswires

18 days ago

RBC Cuts Price Target on Sage Therapeutics to $12 From $15, Keeps Sector Perform Rating

SAGE

MT Newswires

a month ago

JPMorgan Adjusts Price Target on Sage Therapeutics to $23 From $28, Maintains Overweight Rating

SAGE's Huntington's Disease Study Meets Primary Endpoint
SAGE

Zacks

a month ago

SAGE's Huntington's Disease Study Meets Primary Endpoint

SAGE

MT Newswires

2 months ago

Sage Therapeutics Says Phase 2 SURVEYOR Trial Met Primary Endpoint

Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease
SAGE

Business Wire

2 months ago

Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
SAGE

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
SAGE

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
SAGE

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
SAGE

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

SAGE

Insider Monkey

2 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
SAGE

AFP

2 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
SAGE

Investor's Business Daily

2 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
SAGE

The Wall Street Journal

2 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Intermediate Capital Group plc: Notification of Transactions of Directors
SAGE

GlobeNewswire

2 months ago

Intermediate Capital Group plc: Notification of Transactions of Directors

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.
SAGE

ACCESSWIRE

2 months ago

Argus Research Updated Equity Report Coverage On Tego Cyber Inc.

Lyft stock earns multiple upgrades after investor day
SAGE

Yahoo Finance Video

2 months ago

Lyft stock earns multiple upgrades after investor day

Finally, I can make my iPhone look like total crap
SAGE

Engadget

2 months ago

Finally, I can make my iPhone look like total crap

Stock Split Watch: 3 Growth Stocks That Could Be Next
SAGE

Motley Fool

2 months ago

Stock Split Watch: 3 Growth Stocks That Could Be Next

Intermediate Capital Group plc: Vesting in Share Awards/ Notification of Transactions of Directors
SAGE

GlobeNewswire

2 months ago

Intermediate Capital Group plc: Vesting in Share Awards/ Notification of Transactions of Directors

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers
SAGE

PR Newswire

2 months ago

Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers

Decarbonization of European Refineries: A First Agreement Signed Between TotalEnergies and Air Products for the Delivery of Green Hydrogen
SAGE

Business Wire

2 months ago

Decarbonization of European Refineries: A First Agreement Signed Between TotalEnergies and Air Products for the Delivery of Green Hydrogen

Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
SAGE

Business Wire

2 months ago

Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

SAGE

Investing.com

2 months ago

Baird predicts steady growth for SAGE Therapeutics at $15 target

American downgraded, United upgraded: Wall Street's top analyst calls
SAGE

The Fly

2 months ago

American downgraded, United upgraded: Wall Street's top analyst calls

SAGE

MT Newswires

2 months ago

Baird Initiates Sage Therapeutics With Neutral Rating, $15 Price Target

15 Most Depressed States in the US
SAGE

Insider Monkey

2 months ago

15 Most Depressed States in the US

Sage Therapeutics to Participate in Upcoming May Investor Conferences
SAGE

Business Wire

3 months ago

Sage Therapeutics to Participate in Upcoming May Investor Conferences

Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
SAGE

Insider Monkey

3 months ago

Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript

Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates
SAGE

Simply Wall St.

3 months ago

Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates

Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
SAGE

Zacks

3 months ago

Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates

Sage Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
SAGE

Simply Wall St.

3 months ago

Sage Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

SAGE

MT Newswires

3 months ago

Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained

SAGE

GuruFocus.com

3 months ago

Sage Therapeutics Inc (SAGE) Q1 2024 Earnings: Mixed Results Amidst Pipeline Progress

Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates
SAGE

Zacks

3 months ago

Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
SAGE

Business Wire

3 months ago

Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
SAGE

Zacks

3 months ago

Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal

Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
SAGE

Zacks

3 months ago

Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Sage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark
SAGE

Investor's Business Daily

3 months ago

Sage Stock Collapses To Record Low After Parkinson's Drug Misses Its Mark

Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
SAGE

Benzinga

3 months ago

Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data

Sage Therapeutics Hammered After Parkinson's Drug Misses The Mark
SAGE

Investor's Business Daily

3 months ago

Sage Therapeutics Hammered After Parkinson's Drug Misses The Mark

Sage’s cognition drug fails in Parkinson’s study
SAGE

BioPharma Dive

3 months ago

Sage’s cognition drug fails in Parkinson’s study

SAGE

Reuters

3 months ago

Sage Therapeutics' Parkinson's drug fails in mid-stage study

Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease
SAGE

Business Wire

3 months ago

Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease

12 Best All-Time Low Stocks To Invest In
SAGE

Insider Monkey

3 months ago

12 Best All-Time Low Stocks To Invest In

Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
SAGE

Business Wire

4 months ago

Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024

12 Best Depressed Stocks To Buy in 2024
SAGE

Insider Monkey

4 months ago

12 Best Depressed Stocks To Buy in 2024

New postpartum depression drugs are here. Diagnosis, treatment hurdles still stand in the way.
SAGE

BioPharma Dive

4 months ago

New postpartum depression drugs are here. Diagnosis, treatment hurdles still stand in the way.

We're Keeping An Eye On Sage Therapeutics' (NASDAQ:SAGE) Cash Burn Rate
SAGE

Simply Wall St.

4 months ago

We're Keeping An Eye On Sage Therapeutics' (NASDAQ:SAGE) Cash Burn Rate

25 Most Stressed Cities in the United States
SAGE

Insider Monkey

4 months ago

25 Most Stressed Cities in the United States

Why Is Sage Therapeutics, Inc. (SAGE) Down 22% Since Last Earnings Report?
SAGE

Zacks

4 months ago

Why Is Sage Therapeutics, Inc. (SAGE) Down 22% Since Last Earnings Report?

Sage Therapeutics to Present at Upcoming March Investor Conferences
SAGE

Business Wire

5 months ago

Sage Therapeutics to Present at Upcoming March Investor Conferences

Sage Therapeutics Full Year 2023 Earnings: Beats Expectations
SAGE

Simply Wall St.

5 months ago

Sage Therapeutics Full Year 2023 Earnings: Beats Expectations

Sage Therapeutics (SAGE) Q4 Earnings & Revenues Beat Estimates
SAGE

Zacks

5 months ago

Sage Therapeutics (SAGE) Q4 Earnings & Revenues Beat Estimates

Sage Therapeutics, Inc. (NASDAQ:SAGE) Q4 2023 Earnings Call Transcript
SAGE

Insider Monkey

5 months ago

Sage Therapeutics, Inc. (NASDAQ:SAGE) Q4 2023 Earnings Call Transcript

Estimating The Fair Value Of Sage Therapeutics, Inc. (NASDAQ:SAGE)
SAGE

Simply Wall St.

5 months ago

Estimating The Fair Value Of Sage Therapeutics, Inc. (NASDAQ:SAGE)

Sage Therapeutics Inc (SAGE) Reports Fourth Quarter and Full Year 2023 Financial Results
SAGE

GuruFocus.com

5 months ago

Sage Therapeutics Inc (SAGE) Reports Fourth Quarter and Full Year 2023 Financial Results

Sage offers details on launch of new postpartum depression pill
SAGE

BioPharma Dive

5 months ago

Sage offers details on launch of new postpartum depression pill

Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
SAGE

Business Wire

5 months ago

Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress

Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline
SAGE

Zacks

6 months ago

Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline

Will Sage Therapeutics, Inc. (SAGE) Report Negative Earnings Next Week? What You Should Know
SAGE

Zacks

6 months ago

Will Sage Therapeutics, Inc. (SAGE) Report Negative Earnings Next Week? What You Should Know

Sage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024
SAGE

Business Wire

6 months ago

Sage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024

Is 2024 the Year for Palo Alto Networks Stock?
SAGE

Motley Fool

6 months ago

Is 2024 the Year for Palo Alto Networks Stock?

Columbia Financial (CLBK) Surpasses Q4 Earnings and Revenue Estimates
SAGE

Zacks

6 months ago

Columbia Financial (CLBK) Surpasses Q4 Earnings and Revenue Estimates

Oil Climbs Above $75 as Winter Shut-Ins Lead to Big Stock Draw
SAGE

Zacks

6 months ago

Oil Climbs Above $75 as Winter Shut-Ins Lead to Big Stock Draw

Bank of Hawaii (NYSE:BOH) Is Paying Out A Dividend Of $0.70
SAGE

Simply Wall St.

6 months ago

Bank of Hawaii (NYSE:BOH) Is Paying Out A Dividend Of $0.70

ASTEC Appoints Two New Members to Board of Directors, One Director Retiring
SAGE

GlobeNewswire

6 months ago

ASTEC Appoints Two New Members to Board of Directors, One Director Retiring

Why Is Winnebago (WGO) Down 6.4% Since Last Earnings Report?
SAGE

Zacks

6 months ago

Why Is Winnebago (WGO) Down 6.4% Since Last Earnings Report?

RLX Technology Unveils 2022-2023 Corporate Social Responsibility Report
SAGE

PR Newswire

6 months ago

RLX Technology Unveils 2022-2023 Corporate Social Responsibility Report

Nuclear Energy Stocks Are Surging While the Market Is Floundering
SAGE

InvestorPlace

6 months ago

Nuclear Energy Stocks Are Surging While the Market Is Floundering

SAGE

Associated Press Finance

6 months ago

Texas Capital: Q4 Earnings Snapshot

AssetMark Launches Tax Management Services to Help Advisors Unlock Tax Efficiencies for Their Clients
SAGE

GlobeNewswire

6 months ago

AssetMark Launches Tax Management Services to Help Advisors Unlock Tax Efficiencies for Their Clients

Q3 Earnings Roundup: CarGurus (NASDAQ:CARG) And The Rest Of The Online Marketplace Segment
SAGE

StockStory

6 months ago

Q3 Earnings Roundup: CarGurus (NASDAQ:CARG) And The Rest Of The Online Marketplace Segment

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
SAGE

Zacks

6 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Carter’s, Inc. Announces Leadership Changes
SAGE

Business Wire

6 months ago

Carter’s, Inc. Announces Leadership Changes

Zacks.com featured highlights include GigaCloud Technology, SkyWest, Ramaco Resources, Eastman Chemical and Catalyst Pharmaceuticals
SAGE

Zacks

6 months ago

Zacks.com featured highlights include GigaCloud Technology, SkyWest, Ramaco Resources, Eastman Chemical and Catalyst Pharmaceuticals

HASI Announces Add-On Private Offering of $100 Million Green Senior Unsecured Notes
SAGE

Business Wire

7 months ago

HASI Announces Add-On Private Offering of $100 Million Green Senior Unsecured Notes

Avient To Hold Fourth Quarter 2023 Conference Call
SAGE

PR Newswire

7 months ago

Avient To Hold Fourth Quarter 2023 Conference Call

Wall Street Analysts Believe Smartsheet (SMAR) Could Rally 25.47%: Here's is How to Trade
SAGE

Zacks

7 months ago

Wall Street Analysts Believe Smartsheet (SMAR) Could Rally 25.47%: Here's is How to Trade

Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference
SAGE

Business Wire

7 months ago

Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference

Sage Therapeutics Announces Changes to Board of Directors
SAGE

Business Wire

7 months ago

Sage Therapeutics Announces Changes to Board of Directors

agilon health Announces Tim Bensley to Retire as CFO
SAGE

Business Wire

7 months ago

agilon health Announces Tim Bensley to Retire as CFO

4 Top Stocks to Buy From a Promising Security and Safety Services Industry
SAGE

Zacks

7 months ago

4 Top Stocks to Buy From a Promising Security and Safety Services Industry

Share on Social Networks: